Huapont Life Sciences Co., Ltd.

Simbol: 002004.SZ

SHZ

4.42

CNY

Tržna cena danes

  • 32.7334

    Razmerje P/E

  • 0.7053

    Razmerje PEG

  • 8.58B

    Kapaciteta MRK

  • 0.05%

    Donos DIV

Huapont Life Sciences Co., Ltd. (002004-SZ) Finančni izkazi

Na grafu so prikazane privzete številke v dinamiki za Huapont Life Sciences Co., Ltd. (002004.SZ). Prihodki podjetja prikazujejo povprečje 4719.527 M, ki je 0.415 % gowth. Povprečni bruto dobiček za celotno obdobje je 1826.221 M, ki je 0.211 %. Povprečno razmerje bruto dobička je 0.518 %. Rast čistega dobička za lanskoletno poslovanje podjetja je -0.732 %, kar je enako 0.246 % % v povprečju v celotni zgodovini podjetja.,

Bilanca stanja

Če pogledamo fiskalno pot podjetja Huapont Life Sciences Co., Ltd., opazimo povprečno rast sredstev. Zanimivo je, da ta stopnja znaša , kar odraža tako visoke kot tudi padce podjetja. Pri primerjavi četrtletja s četrtletjem se ta številka prilagodi na 0. Pogled nazaj v preteklo leto razkrije skupno spremembo sredstev v višini 0.023. Na področju kratkoročnih sredstev 002004.SZ znaša 11387.4 v valuti poročanja. Velik del teh sredstev, natančneje 4413.135, je v denarju in kratkoročnih naložbah. V tem segmentu se je ob primerjavi s podatki za preteklo leto spremenil za -0.098%. Dolgoročne naložbe podjetja, ki sicer niso v središču njegovega zanimanja, znašajo 2253.482, če obstajajo, v valuti poročanja. To pomeni razliko v višini 0.870% glede na zadnje obdobje poročanja, kar odraža strateške premike družbe. Dolgoročni profil podjetja kaže skupni dolgoročni dolg v višini 2932.089 v valuti poročanja. Ta številka pomeni medletno spremembo v višini 0.072%. Vrednost za delničarje, kot jo prikazuje celotni lastniški kapital, je ovrednotena z vrednostjo 10105.177 v valuti poročanja. Letna sprememba tega vidika je -0.009%. Podrobnejši pregled finančnih podatkov podjetja razkrije dodatne podrobnosti. Neto terjatve so ovrednotene na 2844.748, zaloge na 2674.61, dobro ime pa na 2739.93, če obstaja. Celotna neopredmetena sredstva, če so prisotna, so ovrednotena z vrednostjo 1652.44. Obveznosti in kratkoročni dolgovi so 1.46 oziroma {{short_term_deby}}. Celotni dolg je 8625.84, neto dolg pa je 4842.99. Druge kratkoročne obveznosti znašajo 29.69 in se dodajo k skupnim obveznostim 14142.66. Nazadnje se navedena zaloga vrednoti po vrednosti {{preffered_stock}}, če obstaja.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

balance-sheet.row.cash-and-short-term-investments

18416.544413.14892.95416.6
4984.7
4051.3
4348.9
7706.6
6032.9
5965
2773.5
1245.3
853
657.4
146.9
165.4
184.1
160.5
106
132.9
240.1
33.4
36.7
23.1

balance-sheet.row.short-term-investments

2174.44630.3706.31030.4
862.3
684.9
-1317.4
0.2
-650.1
-160.6
2.8
79.2
87.9
0
0.2
0
0
0
7.6
7.3
3.6
0
0
0

balance-sheet.row.net-receivables

12013.252844.73059.73587.9
2777.3
2921
3276.9
3708.8
3119.4
2150.5
1379.8
1454.9
1489.1
943.1
170.5
145.8
135.1
286
68.8
65.8
64.6
36.3
76.5
34.9

balance-sheet.row.inventory

10688.672674.62535.62402.3
1951
2092.1
1949.9
1933.8
1502.6
1212.5
942.3
675.6
551.5
400
144.6
116.5
105.4
93.8
84.2
20.1
19.8
17.3
29.4
32.7

balance-sheet.row.other-current-assets

5150.151454.91066907.2
1090
994.5
1426.1
1339.6
1874.4
245.8
352.6
93.4
-158.3
-126.5
-34.3
-11.3
-9.3
-60.1
0.2
-12.1
-14.5
-1.7
-2.7
-4.1

balance-sheet.row.total-current-assets

46268.6111387.411554.212314.1
10803
10058.8
11001.8
14688.9
12529.2
9573.8
5448.2
3469.3
2735.3
1874
427.7
416.4
415.3
480.1
259.2
206.7
310
85.3
139.9
86.5

balance-sheet.row.property-plant-equipment-net

38610.8810024.58917.68052.8
7628.5
7098.6
6331.7
5224.1
3141.3
3226.6
2824.9
1613.6
1304.6
824.4
417.8
402.5
421.6
402.1
324.4
144.5
118.1
52
48.2
40.8

balance-sheet.row.goodwill

11376.062739.92948.13439.9
3465.1
3465.1
3531.2
3606.2
3124.1
2984.7
1678.3
1072.4
949.6
869.4
21.9
21.9
23.1
30.7
0
0
0
0
0
0

balance-sheet.row.intangible-assets

6781.251652.41759.31731
1644
1461
1493.2
1485.9
1289.1
1183.5
569
414.6
395.1
235.9
99.4
62.3
63.9
89.4
77.4
51.3
48
71
1.5
0.3

balance-sheet.row.goodwill-and-intangible-assets

18157.314392.44707.45170.9
5109.1
4926.1
5024.4
5092.1
4413.2
4168.2
2247.3
1486.9
1344.7
1105.3
121.4
84.2
87
120.1
77.4
51.3
48
71
1.5
0.3

balance-sheet.row.long-term-investments

9562.982253.522341503.3
1742.5
1805.6
3531.1
2247.5
3628.1
2329.5
2696.1
909.6
367.7
0
360.5
0
0
0
95.4
67
1.1
0
0
0

balance-sheet.row.tax-assets

1649.71434337.1266.2
355
338.8
274.9
255
153.3
111.7
67.9
23
24.4
15.9
13.7
9.9
12.3
10.3
0
0
3.6
0
0
0

balance-sheet.row.other-non-current-assets

8760.432235.62274.12737.1
2588
2408.6
387.7
1582.5
362.7
300.6
283.7
145.2
145.5
369.8
17.3
230.1
203.2
76
8.6
8.3
0.3
17.5
17.5
5.8

balance-sheet.row.total-non-current-assets

76741.321934018470.217730.4
17423.1
16577.6
15549.7
14401.2
11698.7
10136.6
8119.9
4178.4
3186.9
2315.4
930.7
726.6
724
608.5
505.8
271.2
171.1
140.4
67.2
47

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

123009.9330727.430024.430044.4
28226.1
26636.4
26551.5
29090
24227.9
19710.4
13568.1
7647.6
5922.2
4189.4
1358.4
1143
1139.3
1088.6
765.1
477.9
481
225.7
207.1
133.4

balance-sheet.row.account-payables

9675.352702.92374.82439.3
1758.8
1527.7
1762.7
1956.2
1730.5
1178.9
1261.3
1032
1033.8
665.1
75.7
40.7
77.4
34
29.7
6.8
18.5
11
4.9
6.4

balance-sheet.row.short-term-debt

24167.285693.862646294.5
7294.8
6908.1
6972.7
6005
6284.7
2760.3
2941.4
1480.9
1318.6
632.7
114.5
84.2
151.6
199
125.6
0
22
35
68
13

balance-sheet.row.tax-payables

916.31177313.2226.6
223.8
189.1
206.8
157.2
89.3
89.4
61.8
-20.6
-24.3
11.6
21.2
21.1
21.5
20.1
3.6
3.5
6.7
2.8
3.6
6

balance-sheet.row.long-term-debt-total

10912.672932.11783.72273.2
1838.6
2013.6
2752.1
5499.5
2695.3
3558.2
3025.9
124.1
21.8
46
1.2
1.7
1.7
32.3
5
0
0
10
0
5

Deferred Revenue Non Current

1144.41271.2278.2258.1
224.9
152.7
142.7
112.9
99.8
78.4
61.2
64.5
92.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

430.25---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

149.5929.72134.1469
756.7
1018.4
572.4
969.6
1991
1066.4
47
418.8
46.3
29.8
11.3
7.8
8.8
3.3
7.6
25.3
4.1
1.5
0.8
0.8

balance-sheet.row.total-non-current-liabilities

13263.793508.923622831.4
2368.6
2432.4
3151.4
5810.4
2902.9
3741.9
3241.1
330.1
219.2
116.4
22.6
29.4
17.6
44.1
12.9
5
9.3
19.3
0.6
6.1

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

189.0347.641.951.6
34.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

56250.3814142.713473.614220.7
14089.4
13392.7
13802.3
15793.4
13523.6
9300
7836.2
3635.3
2965.4
1603.5
322.6
245.7
325.3
357.8
242.2
37.2
79.4
80
104.9
45.9

balance-sheet.row.preferred-stock

84.9584.900
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

7919.681979.91979.91979.9
1979.9
1979.9
2034.8
2034.8
2034.8
2034.9
675.7
580.7
502.5
167.5
132
132
132
132
132
132
132
66
66
66

balance-sheet.row.retained-earnings

9945.122336.82544.82646.9
2464.5
2309
2182.7
2127.1
1953.8
1841.5
1456.9
1258
1152.9
923.1
627.9
507.7
427.3
345.9
138.9
126
81.7
59.5
25.5
18.3

balance-sheet.row.accumulated-other-comprehensive-income-loss

12339.24-84.9890.3719.2
689.5
654.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

10549.875788.547774763.4
4495.6
4397.5
4847.4
5331
5656.6
5646.8
3443.2
1958.5
1027.3
1302.5
215.6
198.3
193.7
191.8
179.8
172.8
164.6
19.1
9.1
3.2

balance-sheet.row.total-stockholders-equity

40838.8510105.21019210109.4
9629.5
9340.8
9064.9
9493
9645.2
9523.1
5575.7
3797.3
2682.7
2393.1
975.5
838
753
669.7
450.7
430.9
378.4
144.6
100.7
87.5

balance-sheet.row.total-liabilities-and-stockholders-equity

123009.9330727.430024.430044.4
28226.1
26636.4
26551.5
29090
24227.9
19710.4
13568.1
7647.6
5922.2
4189.4
1358.4
1143
1139.3
1088.6
765.1
477.9
481
225.7
207.1
133.4

balance-sheet.row.minority-interest

25920.716479.66358.85714.4
4507.2
3903
3684.2
3803.6
1059
887.3
156.2
215
274.2
192.9
60.3
59.3
61
61.2
72.2
9.8
23.3
1.2
1.5
0

balance-sheet.row.total-equity

66759.5616584.716550.815823.7
14136.7
13243.7
12749.2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

123009.93---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

11737.432883.82940.32533.7
2604.7
2490.4
2213.7
2247.7
2978
2168.9
2698.9
988.8
455.6
307.1
360.7
213.3
202.2
75.1
103
74.3
4.7
17.1
17.1
5.3

balance-sheet.row.total-debt

35079.958625.88047.78567.7
9133.4
8921.7
9724.9
11504.5
8980
6318.5
5967.4
1605
1340.4
678.7
115.7
85.9
153.3
231.3
130.6
0
22
45
68
18

balance-sheet.row.net-debt

18837.8548433861.14181.5
5011
5555.3
5376
3798.1
2947.1
353.5
3196.6
438.9
575.3
21.3
-30.9
-79.5
-30.8
70.8
32.3
-125.7
-214.5
11.6
31.3
-5.1

Izkaz denarnih tokov

V zadnjem obdobju se je v finančnem okolju Huapont Life Sciences Co., Ltd. opazno spremenil prosti denarni tok, ki se je spremenil v -0.761. Podjetje je nedavno povečalo svoj osnovni kapital z izdajo 0, kar kaže na razliko 0.000 v primerjavi s prejšnjim letom. Zanimivo je, da je del delnic podjetja, natančneje 0, odkupilo podjetje samo. To dejanje je povzročilo spremembo v 0.000 v primerjavi s prejšnjim letom. Medtem pa obveznosti podjetja trenutno znašajo 1.46 v valuti poročanja. Družba je pri naložbenju porabila neto denarna sredstva v višini -556492650.870 v valuti poročanja. To je premik za -0.296 v primerjavi s prejšnjim letom. V istem obdobju je družba zabeležila 800.23, -176.39 in -7897.82, ki so pomembne za razumevanje naložbenih in odplačilnih strategij podjetja. Družba je pri financiranju porabila 0.000, pri čemer je razlika v primerjavi z letom prej znašala 0.000. Poleg tega je podjetje namenilo -854.41 za izplačilo dividend svojim delničarjem. Hkrati je izvajalo tudi druge finančne manevre, imenovane 7381.97, ki so prav tako pomembno vplivali na denarni tok v tem obdobju. Te sestavine skupaj tvorijo celovito sliko finančnega stanja podjetja in strateškega pristopa k upravljanju denarnih tokov.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008200720062005200420032002

cash-flows.row.net-income

280.541126.7925895
931.9
822.8
593.7
611.7
656.8
446
317
370.8
308.4
135.2
129.2
90.1
222.6
58.9
51.9
46.9
39.6
36.8

cash-flows.row.depreciation-and-amortization

696.35800.2747.9696.3
607.1
586.8
387.2
330.8
319.8
210.5
132.4
106.4
39.3
36.6
41.8
38
28.6
13.2
12.2
8.1
6.1
4.4

cash-flows.row.deferred-income-tax

0-68.611.4-25.5
-60.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

049.5-11.413
8.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

-800.57-162.1-843.9294.8
28.8
-30.7
-660.8
-654.6
-741.5
-312.2
-185.8
-194.5
-12.1
-58.7
-17.4
1.3
-4.2
-0.1
-19.7
14.3
4.7
-9.2

cash-flows.row.account-receivables

-587.9859.6-1039.7-128.8
-29.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

-201.92-154.6-456.1142.2
-144.9
-15.3
-36.7
-320.8
-148.5
-162.5
-84.7
-32.3
-10.5
-29.8
-15
-25
-9.7
-6.7
-0.1
-2.3
12
3.2

cash-flows.row.account-payables

01.5645.4306.9
264
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

-10.67-68.66.4-25.5
-60.7
-15.3
-624.1
-333.8
-593
-149.7
-101.1
-162.2
-1.6
-28.9
-2.4
26.2
5.5
6.6
-19.7
16.6
-7.2
-12.4

cash-flows.row.other-non-cash-items

1553.85662.1440.7499.1
566.2
529.7
271.4
224.1
107.3
111.7
85.9
-24.9
-200.4
-33.2
-30.1
-15.6
-167.8
-5.9
-0.7
1.2
6.3
4.9

cash-flows.row.net-cash-provided-by-operating-activities

1730.18000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-1379.1-1131.2-1256.4-1231.2
-1433.5
-1099.4
-972.7
-651.2
-831.8
-585.5
-379.8
-315.2
-95.8
-56.9
-73.5
-92.5
-124
-47.8
-44.4
-26.8
-30.8
-52.7

cash-flows.row.acquisitions-net

16.29-15.8-40.129.8
64.7
-15.4
-172.6
-187.7
-37.2
-191.1
-115.7
-171.8
211.3
0.3
25.8
2.5
0.7
0.8
0.1
0
0
0

cash-flows.row.purchases-of-investments

-8385.3-7141.8-7267.4-10125.4
-7001.5
-9954
-7235.2
-5852.7
-1196.1
-3693
-851.2
-143.7
-106.5
-138.1
-39
-72
-411.3
-122.9
-90.1
0
0
-13.2

cash-flows.row.sales-maturities-of-investments

7625.577908.87749.19612.7
6969.8
9774.9
7656.3
3526.8
1521.3
1778.9
299.4
55.1
38.8
42.1
51.5
91.9
427.5
40.5
4.3
0
0
0

cash-flows.row.other-investing-activites

-161.49-176.424.4-46.2
41.3
268.5
1066.7
138.8
-112.8
6.2
18.1
-10.7
30.8
-34.9
11.5
10.5
4.5
27.6
2
19.9
4
0.2

cash-flows.row.net-cash-used-for-investing-activites

-2275.27-556.5-790.4-1760.3
-1359.2
-1025.5
342.5
-3026
-656.6
-2684.5
-1029.3
-586.3
78.7
-187.5
-23.6
-59.6
-102.7
-101.7
-128.1
-6.9
-26.8
-65.7

cash-flows.row.debt-repayment

-6196.07-7897.8-10279-11984.1
-10747.2
-8972.5
-10000.8
-5988.2
-4494.4
-3215.5
-1978.7
-936.2
-174.7
-122.5
-188
-323.4
-134.2
0
-26
-107
-73
-13

cash-flows.row.common-stock-issued

000-4.6
-5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0004.6
5.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

-761.1-854.4-859.4-943.1
-966.5
-988
-761.5
-783.6
-517.9
-408.2
-270.2
-185.2
-14.1
-10.2
-52.4
-19
-14.4
-40.4
-0.4
-19.2
-19.7
-9.7

cash-flows.row.other-financing-activites

5333.16738210934.712687.6
10085.9
6751.9
11794.8
8615.4
8085.2
5937.7
3425.9
1364.7
354.5
204.8
129.9
298.3
232.8
48.7
0
265.6
59.6
65.1

cash-flows.row.net-cash-used-provided-by-financing-activities

734.91-1370.3-203.8-239.6
-1627.8
-3208.6
1032.5
1843.6
3072.9
2314
1177
243.3
165.7
72
-110.5
-44.1
84.3
8.3
-26.4
139.4
-33.1
42.4

cash-flows.row.effect-of-forex-changes-on-cash

18.387.311.1-30.1
10.1
60.7
-121.4
52.3
85.1
-6.7
-37.7
-4.3
-4.9
3
-0.6
1.2
-0.3
0
0
0
0
0

cash-flows.row.net-change-in-cash

191.84488.4286.5342.8
-894.8
-2264.7
1845
-618.2
2843.9
78.7
459.5
-89.5
374.7
-32.6
-11.1
11.3
60.5
-27.3
-110.9
203.1
-3.3
13.6

cash-flows.row.cash-at-end-of-period

12298.852991.325032216.5
1873.7
2767.7
5022.1
3177.2
3795.3
951.4
871.2
411.7
501.2
126.5
159.1
170.2
158.9
98.4
125.7
236.5
33.4
36.7

cash-flows.row.cash-at-beginning-of-period

12107.0225032216.51873.7
2768.5
5032.4
3177.2
3795.3
951.4
872.7
411.7
501.2
126.5
159.1
170.2
158.9
98.4
125.7
236.5
33.4
36.7
23.1

cash-flows.row.operating-cash-flow

1730.182407.91269.62372.7
2082.1
1908.6
591.4
511.9
342.4
456
349.5
257.8
135.2
79.8
123.5
113.8
79.2
66.1
43.7
70.6
56.7
36.9

cash-flows.row.capital-expenditure

-1379.1-1131.2-1256.4-1231.2
-1433.5
-1099.4
-972.7
-651.2
-831.8
-585.5
-379.8
-315.2
-95.8
-56.9
-73.5
-92.5
-124
-47.8
-44.4
-26.8
-30.8
-52.7

cash-flows.row.free-cash-flow

351.081276.713.21141.6
648.7
809.2
-381.3
-139.3
-489.3
-129.6
-30.3
-57.5
39.5
23
50.1
21.3
-44.8
18.3
-0.7
43.8
25.9
-15.8

Vrstica izkaza poslovnega izida

Prihodki Huapont Life Sciences Co., Ltd. so se v primerjavi s prejšnjim obdobjem spremenili za -0.124%. Bruto dobiček podjetja 002004.SZ znaša 4535.07. Odhodki iz poslovanja podjetja so 3032.17 in so se v primerjavi s prejšnjim letom spremenili za -9.489%. Odhodki za amortizacijo znašajo 800.23, kar je 0.114% sprememba glede na zadnje obračunsko obdobje. Stroški poslovanja so sporočeni v višini 3032.17, ki kaže -9.489% spremembo glede na preteklo leto. Stroški prodaje in trženja znašajo 0, kar pomeni 0.000% spremembo v primerjavi s preteklim letom. EBITDA na podlagi zadnjih podatkov znaša 0 in predstavlja -0.651% rast v primerjavi s preteklim letom. Prihodki iz poslovanja so 926.51, ki kažejo -0.651% spremembo v primerjavi s preteklim letom. Sprememba čistih prihodkov je -0.732%. Čisti prihodki v zadnjem letu so znašali 302.12.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001

income-statement-row.row.total-revenue

11534.5311594.613232.412359.2
10876.4
10091.4
10573.6
9108.9
7092.8
6174.3
4866.7
4463.6
3877.4
638.1
541.2
544.5
575.7
492.4
285.2
273.5
272.5
240.4
200.2
174.1

income-statement-row.row.cost-of-revenue

7096.247059.57874.17605.6
6421.3
5395.8
6281.7
6195.1
4752.6
4040.4
3383.5
3297.1
2892.8
211.7
176.9
189.7
203.2
182.6
63.7
63.2
64.6
70.7
64
56.4

income-statement-row.row.gross-profit

4438.294535.15358.34753.6
4455
4695.6
4292
2913.8
2340.2
2133.9
1483.2
1166.6
984.5
426.4
364.3
354.8
372.6
309.7
221.6
210.3
208
169.7
136.2
117.6

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

412.1---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

432.26---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

1317.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

-30.25-34.1921.7784.4
599.4
646.4
636
418
83.6
-14.1
6.1
11.3
24.7
20.8
8.9
14.7
3.6
0.9
0.8
0.3
0.1
2.2
-0.2
-0.2

income-statement-row.row.operating-expenses

3043.23032.233503130
2896.7
3107.6
2865.7
1987.3
1501.2
1299.6
918.1
710.9
585.5
320.1
256.1
251.9
288.6
231
159.5
150.7
149
121.6
89.6
81.6

income-statement-row.row.cost-and-expenses

10139.4410091.711224.110735.6
9318
8503.4
9147.4
8182.3
6253.8
5340
4301.6
4008
3478.4
531.9
432.9
441.6
491.8
413.6
223.2
213.9
213.6
192.3
153.6
138

income-statement-row.row.interest-income

86.5485.28880.9
77.5
69.5
120.4
137.6
92.8
108.3
32.7
25.4
9.6
3.6
2.2
0
3.4
2.5
1.6
3
1
0.2
0.2
0.1

income-statement-row.row.interest-expense

345.8343.7434461.7
561.1
565.4
605
529.6
372.4
331.6
215.7
89.2
87.4
12.6
8
7.6
19.5
14.5
0.8
0.4
1.7
3.2
1.8
0.4

income-statement-row.row.selling-and-marketing-expenses

1317.3---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-30.25-34.1-1031.2-607.9
-575.1
-683.1
-698.6
-457.4
-138.7
-77
-68.1
-65
47.1
219.6
43.3
44.5
18.9
167.3
6.5
2.5
-0.4
-3.2
-3
-0.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

-30.25-34.1921.7784.4
599.4
646.4
636
418
83.6
-14.1
6.1
11.3
24.7
20.8
8.9
14.7
3.6
0.9
0.8
0.3
0.1
2.2
-0.2
-0.2

income-statement-row.row.total-operating-expenses

-30.25-34.1-1031.2-607.9
-575.1
-683.1
-698.6
-457.4
-138.7
-77
-68.1
-65
47.1
219.6
43.3
44.5
18.9
167.3
6.5
2.5
-0.4
-3.2
-3
-0.1

income-statement-row.row.interest-expense

345.8343.7434461.7
561.1
565.4
605
529.6
372.4
331.6
215.7
89.2
87.4
12.6
8
7.6
19.5
14.5
0.8
0.4
1.7
3.2
1.8
0.4

income-statement-row.row.depreciation-and-amortization

671.4891.2800.2747.9
696.3
607.1
586.8
387.2
330.8
319.8
210.5
132.4
106.4
39.3
36.6
41.8
38
28.6
13.2
12.2
8.1
6.1
4.4
0.2

income-statement-row.row.ebitda-caps

1510.64---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

839.23926.52653.91893.9
1740.2
1832.4
1772.7
1139.2
657.8
752.8
481.4
384.8
425.9
306.1
149.9
137.4
99.6
246.8
70
63.2
58.9
47.4
44.2
36.2

income-statement-row.row.income-before-tax

808.99892.41622.71286
1165.1
1149.3
1074.1
681.8
700.3
757.3
497
390.7
446.1
325.8
151.5
147.4
102.8
246.1
69.7
62.8
58.8
47.3
43.8
36

income-statement-row.row.income-tax-expense

212.47215.5496361
270.1
217.4
251.3
88.1
88.6
100.5
51
73.7
75.3
17.4
16.4
18.1
12.7
23.4
10.8
10.9
11.9
7.7
7
4.9

income-statement-row.row.net-income

280.54302.11126.7925
895
931.9
822.8
507.9
566.9
636.6
429.2
302.4
332.4
305.3
132
127.7
88.8
206.5
58.4
52.5
47.6
39.9
37.3
31.1

Pogosto zastavljeno vprašanje

Kaj je Huapont Life Sciences Co., Ltd. (002004.SZ) skupna sredstva?

Huapont Life Sciences Co., Ltd. (002004.SZ) skupna sredstva so 30727396560.000.

Kakšen je letni prihodek podjetja?

Letni prihodki so 5657008739.000.

Kolikšna je stopnja dobička podjetja?

Dobiček podjetja je 0.385.

Kakšen je prosti denarni tok podjetja?

Prosti denarni tok je 0.177.

Kolikšna je neto stopnja dobička podjetja?

Čista stopnja dobička je 0.024.

Kolikšni so skupni prihodki podjetja?

Celotni prihodki so 0.073.

Kaj je Huapont Life Sciences Co., Ltd. (002004.SZ) čisti dobiček (čisti dobiček)?

Čisti dobiček (čisti prihodek) je 302122026.000.

Kolikšen je skupni dolg podjetja?

Skupni dolg je 8625844451.000.

Kolikšni so stroški poslovanja?

Stroški poslovanja so 3032172071.000.

Kolikšno je število denarnih sredstev podjetja?

Denarna sredstva podjetja so 4112423354.000.